Exin Therapeutics

South San Francisco, United States

Exin Therapeutics offers next-gen neurotherapeutics leverage machine learning, genome editing, & bioelectronic medicine.

$500K raised

Jan 2025

Pre-Seed

Artificial Intelligence (AI)Biotechnology Therapeutics

Top Investors

Y CombinatorRyan Merket

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Exin Therapeutics

How much funding has Exin Therapeutics raised?

Exin Therapeutics has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2025.

Who are Exin Therapeutics's investors?

Exin Therapeutics's investors include Y Combinator, Ryan Merket.

Where is Exin Therapeutics headquartered?

Exin Therapeutics is headquartered in South San Francisco, United States.

What does Exin Therapeutics do?

Exin Therapeutics offers next-gen neurotherapeutics leverage machine learning, genome editing, & bioelectronic medicine.

What stage is Exin Therapeutics at?

Exin Therapeutics is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 21, 2025.

MLA

"Exin Therapeutics — Funding & Investors." VCBacked, January 21, 2025, https://www.vcbacked.co/company/exin-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2025). Exin Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/exin-therapeutics

Wikipedia (cite web)

{{cite web |title=Exin Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/exin-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 21, 2025.

Similar Companies in Artificial Intelligence (AI)